Drug- or toxin-induced pulmonary arterial hypertension
MONDO:0017149Drug- or toxin-induced pulmonary arterial hypertension (PAH) is a form of pulmonary arterial hypertension (PAH) secondary to the exposition to drugs. Drug- or toxin-induced PAH is characterized by elevated pulmonary arterial resistance leading to right heart failure. Drug or toxin induced PAH is progressive and potentially fatal.
Also known as: drug- or toxin-induced PAH
26 clinical trials for this condition and its sub-types, 4 tagged with Drug- or toxin-induced pulmonary arterial hypertension itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a diabetes drug help PAH patients walk farther?
Symptom relief CompletedThis study tested whether metformin, a common diabetes drug, along with a text-message activity program, could help people with pulmonary artery hypertension (PAH) walk farther and feel better day-to-day. 73 adults with PAH took part. The goal was to see if these interventions im…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Small study aims to unlock secrets of rare lung disease
Knowledge-focused CompletedThis completed Phase 1 study looked at 27 people with and without pulmonary hypertension to learn more about how blood vessel problems contribute to the disease. Researchers used heart catheterization, imaging, and blood tests to find biomarkers and understand disease mechanisms.…
Phase 1 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC